Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
Ekeblad S, Sundin A, Janson ET, Welin S, Granberg D, Kindmark H, Dunder K, Kozlovacki G, Orlefors H, Sigurd M, Oberg K, Eriksson B, Skogseid B.
Ekeblad S, et al. Among authors: janson et.
Clin Cancer Res. 2007 May 15;13(10):2986-91. doi: 10.1158/1078-0432.CCR-06-2053.
Clin Cancer Res. 2007.
PMID: 17505000